Related Experiment Video
Updated: Jan 21, 2026

In Vitro and In Vivo Delivery of Magnetic Nanoparticle Hyperthermia Using a Custom-Built Delivery System
Published on: July 2, 2020
DOTAP-Incorporated PEG-PLGA Nanoparticles for Efficient In Vitro and In Vivo Gene Delivery
Abstract:
The application of nucleic acids as therapeutic agents has been obstructed by the lack of efficient and safe systems for the delivery of the therapeutic DNA into target cells. Nanoparticle (NP) vectors based on biocompatible and biodegradable poly(D,L-lactic-co-glycolic acid) (PLGA) polymers, especially the PEGylated ones, seem to be promising drug delivery systems but are far from being ideal gene delivery systems. Given the broad potential of PEGylated PLGA (PEG-PLGA) NPs in the biomedical applications, here, we designed and optimized a PEG-PLGA NP system by incorporating cationic lipids as the excipients for improving the gene delivery efficiency. Systemic investigation of this system by varying the type of the cationic lipids and PEG-PLGA polymers, preparation conditions, transfection conditions and cell lines was carried out, with the aim of finding a relatively efficient formulation for in vivo gene delivery. The optimized NP system showed excellent pDNA transfection efficacy both in vitro and in vivo, while much lower cytotoxicity than commercial Lipofectamine™ 2000 (Lip2000). The prepared system may be very useful for in vivo delivery of gene therapies to targeted cells.
More Related Videos
Related Concept Videos
Combinatorial Gene Control
The expression of more than 30,000 genes is controlled by approximately 2000-3000 transcription factors. This is possible because a single transcription factor can recognize more than one regulatory sequence. The specificity in gene...
Equivalence: In Vitro and In Vivo Bioequivalence
Gene Therapy
Export of Mitochondrial and Chloroplast Genes
Drug Product Performance: In Vitro–In Vivo Correlation
Gene Flow

